Federal contract award
75D30123C16444
SARS-COV2 INFLUENZA MULTIPLEX
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | CDC OFFICE OF ACQUISITION SERVICES |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $757.6K |
| Current contract value | $757.6K |
| Potential contract value / ceiling | $757.6K |
| Start date | Apr 26, 2023 |
| Current end date | Dec 13, 2023 |
| Potential end date | Dec 13, 2023 |
| Latest award activity | Jun 17, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 17, 2026 | P00002 | $-42.4K | SARS-COV2 INFLUENZA MULTIPLEX |
| Jun 20, 2023 | P00001 | $400.0K | SARS-COV2 INFLUENZA MULTIPLEX |
| Apr 26, 2023 | 0 | $400.0K | SARS-COV2 INFLUENZA MULTIPLEX |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.